Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy

2017 ◽  
Vol 125 (1) ◽  
pp. 48-54 ◽  
Author(s):  
Yutaka Shiraishi ◽  
Cai Xu ◽  
Jinzhong Yang ◽  
Ritsuko Komaki ◽  
Steven H. Lin
2015 ◽  
Vol 42 (6Part12) ◽  
pp. 3336-3336
Author(s):  
N Gallardo ◽  
F Maneru ◽  
N Fuentemilla ◽  
J Olasolo ◽  
M Gracia ◽  
...  

Rare Tumors ◽  
2019 ◽  
Vol 11 ◽  
pp. 203636131987851 ◽  
Author(s):  
Nathan Y Yu ◽  
Sujay A Vora

Retroperitoneal chordomas are exceedingly rare and account for less than 5% of all primary bone malignancies. Their etiology remains unknown. We report a rare case of an extravertebral chordoma of the retroperitoneum in a 71-year-old man treated with surgical resection and post-operative spot-scanning proton beam therapy. We describe how to safely treat a retroperitoneal target to a prescription dose over 70 Gy (relative biological effectiveness) with spot-scanning proton beam therapy and also report a dosimetric comparison of spot-scanning proton beam therapy versus intensity-modulated radiation therapy. This case not only highlights a rare diagnosis of an extravertebral retroperitoneal chordoma but it also draws attention to the dosimetric advantages of proton beam therapy and illustrates a promising radiotherapeutic option for retroperitoneal targets.


Sign in / Sign up

Export Citation Format

Share Document